Growing community of inventors

Toyonaka, Japan

Yujiro Kidani

Average Co-Inventor Count = 12.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Yujiro KidaniAtsushi Tanaka (80 patents)Yujiro KidaniAtsushi Tanaka (2 patents)Yujiro KidaniTetsuya Yoshida (2 patents)Yujiro KidaniNorio Nonomura (2 patents)Yujiro KidaniShimon Sakaguchi (2 patents)Yujiro KidaniHisashi Wada (2 patents)Yujiro KidaniMitsunobu Matsumoto (2 patents)Yujiro KidaniNaganari Ohkura (2 patents)Yujiro KidaniTakayuki Kanazawa (2 patents)Yujiro KidaniAtsunari Kawashima (2 patents)Yujiro KidaniSatomi Shinonome (2 patents)Yujiro KidaniKanji Hojo (2 patents)Yujiro KidaniYujiro Kidani (2 patents)Atsushi TanakaAtsushi Tanaka (80 patents)Atsushi TanakaAtsushi Tanaka (49 patents)Tetsuya YoshidaTetsuya Yoshida (11 patents)Norio NonomuraNorio Nonomura (5 patents)Shimon SakaguchiShimon Sakaguchi (5 patents)Hisashi WadaHisashi Wada (3 patents)Mitsunobu MatsumotoMitsunobu Matsumoto (2 patents)Naganari OhkuraNaganari Ohkura (2 patents)Takayuki KanazawaTakayuki Kanazawa (2 patents)Atsunari KawashimaAtsunari Kawashima (2 patents)Satomi ShinonomeSatomi Shinonome (2 patents)Kanji HojoKanji Hojo (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shionogi Company Limited (2 from 1,001 patents)

2. Osaka University (2 from 987 patents)


2 patents:

1. 11932696 - Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells

2. 10550191 - Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…